公司資料
Cel-Sci Corporation 股價、新聞與催化劑
- 股票代碼:
- CVM
- 交易所:
- AMEX
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.55 USD (+0.65%)
收盤價
最後更新: 2026年8月17日
21.6M USD
市值
股價為何變動
As of Aug 17, 2026, CVM closed up 0.65% at $1.55. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Cel-Sci is a biotechnology company focused on immunotherapy and cancer vaccine approaches. Its story has long centered on a high-risk, high-conviction immune-oncology platform.
所在地與產業分類
Headquartered in the United States and listed on NYSE American, Cel-Sci sits in oncology biotechnology.
商業模式特徵
The company depends on clinical validation, regulatory progress, and the ability to create a differentiated immunotherapy story.
生技產業定位
Cel-Sci is a classic high-beta oncology name whose stock is extremely sensitive to trial outcomes.
未來催化劑
- Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event. The company’s stock remains highly event-driven.
近期新聞
- 01
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。